Search
for
Sort by
Research 61–90 of 137
- Use of modern technological devices (photography, mobile phone applications and artificial intelligence) in dermatology
- 530 A clinical comparison of photobiomodulation devices for the treatment of alopecia in all skin types
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Principles of Hair Cycle Control
- Pimecrolimus interferes the therapeutic efficacy of human mesenchymal stem cells in atopic dermatitis by regulating NFAT-COX2 signaling
- Can Platelet-Rich Plasma Reduce the Burden of Inflammatory Skin Diseases Such as Psoriasis and Atopic Dermatitis?
- Hair Mineral Analysis in Children with Atopic Dermatitis
- Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- PROTACs in 2025: from the laboratory concept to clinical breakthrough
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Universal Dermatology: Bridging Gaps in Skin Health
- Clinical Efficacy of Topical or Oral Soy Supplementation in Dermatology: A Systematic Review
- The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality‐of‐life instruments: A systematic review
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- Editor's Picks February 2021
- Can we teach old drugs new tricks?—Repurposing of neuropharmacological drugs for inflammatory skin diseases
- JAK inhibitors in dermatology: The promise of a new drug class
- Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- The Human Skin Microbiome in Selected Cutaneous Diseases
- The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review
- Potential Therapeutic Applications of Bee Venom on Skin Disease and Its Mechanisms: A Literature Review
- Natural Sources of Therapeutic Agents Used in Skin Conditions
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Under Development JAK Inhibitors for Dermatologic Diseases
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician